Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial pharmaceutics.

Volkmar Weissig1, Shing-Ming Cheng, Gerard G M D'Souza

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, 360 Huntington Avenue, Mugar 211, Boston, MA 02115, USA. v.weissig@neu.edu

Mitochondrion
|August 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

170 Years of Mitochondrial Research and the Emergence of Mitochondrial Medicine.

Journal of clinical pharmacology·2026
Same author

Current challenges in the development of liposomes to target mitochondria.

Nanomedicine (London, England)·2026
Same author

Monosialoganglioside-Containing Nanoliposomes Protect Against Acute and Chronic Ischemic Stroke Injury.

Journal of the American Heart Association·2026
Same author

<i>In vitro</i> cytotoxicity of liposomal stearyl triphenyl phosphonium is influenced by mitochondrial bioenergetics.

Journal of liposome research·2025
Same author

Triple co-culture spheroid models of lung and ovarian carcinoma cell lines for the <i>in vitro</i> testing of antitumor liposomes.

Journal of liposome research·2025
Same author

Cytoprotective effects of liposomal ganglioside GM1.

Journal of liposome research·2025
Same journal

miR-205-5p accelerates lung fibroblast senescence in IPF patients via mediation of mitochondrial dynamics.

Mitochondrion·2026
Same journal

A neuronal model of mtDNA disease reveals an ineffective reprogramming of the electron transfer chain during neuronal maturation.

Mitochondrion·2026
Same journal

ATPIF1, the rheostat in mitochondrial bioenergetics and dysfunction in diseases.

Mitochondrion·2026
Same journal

Spatholobi caulis and Epicatechin amplify erythropoiesis through mitochondrial translocation of AKT and enhanced oxidative phosphorylation.

Mitochondrion·2026
Same journal

DNM1L depletion leads to accelerated heteroplasmy shifting of m.10191C allele through ATG7-dependent pathways.

Mitochondrion·2026
Same journal

Energy beats: Daily and circadian rhythms in mitochondrial biology.

Mitochondrion·2026
See all related articles

Mitochondria, crucial for cell energy and apoptosis, are implicated in numerous diseases. New research in mitochondrial medicine focuses on targeting these organelles for therapeutic benefits, offering potential treatments for various human disorders.

Area of Science:

  • Cell Biology
  • Biomedical Research
  • Pharmacology

Background:

  • Mitochondria, the 'powerhouses' of cells, have been studied for over a century.
  • Recent discoveries since the late 1980s have renewed scientific interest in mitochondria.
  • Mitochondrial dysfunction is linked to diverse human diseases, including neurodegenerative disorders, metabolic diseases, and cancer.

Purpose of the Study:

  • To review current strategies for targeting biologically active molecules to mitochondria.
  • To explore the therapeutic applications of manipulating mitochondrial functions.
  • To highlight the emergence of 'Mitochondrial Medicine' as a new field.

Main Methods:

  • Review of recent scientific literature on mitochondrial targeting strategies.

Related Experiment Videos

  • Analysis of pharmacological and pharmaceutical advancements in the field.
  • Synopsis of current research in mitochondrial medicine.

    • Main Results:

    • Mitochondria play critical roles in cellular energy production and apoptosis ('arsenals').
    • Targeting molecules to mitochondria offers potential for selective cell protection, repair, or eradication.
    • Significant progress has been made in developing therapeutic strategies for mitochondrial dysfunction.

    Conclusions:

    • Mitochondrial medicine is a rapidly advancing field with significant therapeutic potential.
    • Targeted delivery of molecules to mitochondria is key to manipulating cellular functions.
    • Further research promises novel treatments for a wide range of diseases linked to mitochondrial dysfunction.